# Session Log: 2026-05-08

## 1. Infrastructure & Deployment
- **Git & GitHub Integration:**
    - Installed Git for Windows via CLI.
    - Initialized Git repository and configured `.gitignore` to exclude large binaries (`vscode_installer.exe`, `build/`, `dist/`).
    - Successfully pushed the project to GitHub: `https://github.com/darongzhensuo-afk/clinictools`.
    - Enabled GitHub Pages for live web access.
- **UI/UX Maintenance:**
    - Updated `index.html` metadata: Replaced version numbers with "Last Updated" dates for better clinical trust.
    - Fixed Logo Issue: Moved `Logo Clinic.png` into the project root and updated relative paths in `index.html` to ensure visibility on the web.

## 2. Clinical Tool Development
- **Gout & Hyperuricemia Assessment Tool:**
    - **Guideline Research:** Summarized 2024 TASGH (Taiwanese Association for the Study of Gout and Hyperuricemia) updates.
    - **Implementation:** Created `tools/gout/gout_calculator.html`.
    - **Logic:** Includes 2024 criteria for ULT initiation (CKD 3+, OA, and high sUA thresholds) and Treat-to-Target goals (<6.0 or <5.0).
    - **Medication:** Integrated logic for choosing Febuxostat (NHI 1st line for CKD), Allopurinol (HLA-B*5801 warning), and Benzbromarone (urolithiasis contraindication).
- **SGLT2i NHI Reimbursement Assessment Tool:**
    - **Reimbursement Research:** Verified 2026 active status of the March 2025 expansion.
    - **Implementation:** Created `tools/nhi/sglt2i_calculator.html`.
    - **Logic:**
        - **HF:** Expanded to LVEF ≤ 49%.
        - **CKD:** Includes non-diabetic coverage (eGFR 25-60, UACR 200-5000) for patients in care plans.
        - **DM:** Metformin requirement and GLP-1 RA (胰妥讚, 易週糖) concurrent reimbursement restriction.

## 3. Documentation & Memory
- Created `tools/gout/gout_guideline_summary.md`.
- Created `tools/nhi/sglt2i_reimbursement_summary.md`.
- Updated `GEMINI.md` with the "save" directive to automate this logging process.

---
*Status: All changes pushed to main branch on GitHub.*
